Cargando…
Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer
P-glycoprotein (P-gp) is a drug transporter that effluxes chemotherapeutic drugs and is implicated in the development of resistance of cancer cells to chemotherapeutic drugs. To date, no drug has been approved to inhibit P-gp and restore chemotherapy efficacy. Moreover, majority of the reported inhi...
Autores principales: | Syed, Safiulla Basha, Arya, Hemant, Fu, I-Hsuan, Yeh, Teng-Kuang, Periyasamy, Latha, Hsieh, Hsing-Pang, Coumar, Mohane Selvaraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554262/ https://www.ncbi.nlm.nih.gov/pubmed/28801675 http://dx.doi.org/10.1038/s41598-017-08062-2 |
Ejemplares similares
-
Reversible Testicular Toxicity of Piperine on Male Albino Rats
por: Chinta, Gopichand, et al.
Publicado: (2017) -
Mimicking H3 Substrate Arginine in the Design of G9a
Lysine Methyltransferase Inhibitors for Cancer Therapy: A Computational
Study for Structure-Based Drug Design
por: Chandar Charles, M. Ramya, et al.
Publicado: (2021) -
BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2011) -
Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2009) -
Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification
por: Ke, Yi-Yu, et al.
Publicado: (2015)